Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
General Info
Time period covered
January, 2011 - December, 2016
Data type
Scientific literature
Keywords
Citation
Journal
N Engl J Med
Pages
11-22
Publication year
2019
Suggested citation
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM, REDUCE-IT Investigators. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019; 380(1): 11-22.